Granules Eyes Oncology After Exiting Ventures
Plans To Sit On Cash from Omnichem And Biocause Exits
Granules India has ambitions to become a vertically integrated player in cancer therapies after the company ended joint ventures for contract research and manufacturing services as well as for making bulk ibuprofen.
